Respiratory Syncytial Virus (RSV) Diagnostic Market Size

Source Domain: www.openpr.com

The global Respiratory Syncytial Virus (RSV) diagnostic market was valued at USD 1.50 billion in 2025 and is expected to reach USD 4.34 billion by 2035, growing at a CAGR of 11.20%.
Key drivers for this market growth include the rising prevalence of respiratory infections, a growing neonatal population, and advancements in diagnostic technology.
Artificial Intelligence (AI) is transforming the RSV diagnostic market by predicting outbreaks based on trends and aiding in the accurate differentiation of infections.
Regional analysis shows North America leading with a 39.2% share in 2025, while Asia-Pacific is expected to experience the fastest growth.
Product and service analysis highlights kits and assays as the largest segment, but software and services are growing the fastest due to real-time data reliance.

You may have missed